Skip to main content
Photocure ASA logo

Photocure ASA — Investor Relations & Filings

Ticker · PHO ISIN · NO0010000045 LEI · 5967007LIEEXZXG8OW35 OL Manufacturing
Filings indexed 1,320 across all filing types
Latest filing 2021-12-03 Director's Dealing
Country NO Norway
Listing OL PHO

About Photocure ASA

https://www.photocure.com/

Photocure is a specialty pharmaceutical company focused on bladder cancer. It develops and commercializes products and medical devices based on proprietary photodynamic technology. The company's primary offering is Blue Light Cystoscopy (BLC) with its imaging agents, Hexvix®/Cysview®, which is used for the improved detection and management of bladder cancer. Photocure aims to deliver transformative solutions to the urologic oncology community to improve patient outcomes. The company is also engaged in developing advanced diagnostic technologies, including the integration of artificial intelligence with its BLC systems.

Recent filings

Filing Released Lang Actions
Photocure ASA: Exercise of employee share options and share capital increase
Director's Dealing Classification · 100% confidence The document is explicitly titled "NOTIFICATION OF TRANSACTIONS PURSUANT TO THE MARKET ABUSE REGULATION ARTICLE 19". It details a transaction (Purchase of shares) made by a 'Person discharging managerial responsibilities' (Susanne Strauss) concerning the issuer's stock (PHOTOCURE ASA). This structure perfectly matches the definition of Director's Dealing (insider trades) as defined in the provided list. The code for this is DIRS.
2021-12-03 English
Photocure ASA: Exercise of employee share options and share capital increase
Remuneration Information Classification · 99% confidence The document explicitly details the exercise of employee share options, the resulting increase in share capital, and includes notifications regarding primary insider transactions (Director's Dealing). The core subject matter revolves around changes to the company's share structure due to option exercises and insider activity. This aligns most closely with the 'Share Issue/Capital Change' (SHA) category, as it announces the issuance of new shares following option exercises, and also touches upon insider transactions which are often reported alongside capital changes. However, since the primary action described is the issuance of new shares following option exercises, SHA is the most fitting primary classification. The mention of primary insider notifications suggests a secondary element of DIRS, but the main announcement is the capital increase.
2021-12-03 English
Photocure ASA: Exercise of employee share options and share capital increase
Share Issue/Capital Change Classification · 99% confidence The document explicitly details the exercise of employee share options, the resulting increase in share capital, and the issuance of new shares. This directly relates to changes in the company's capital structure and share count. This aligns perfectly with the definition of 'Share Issue/Capital Change' (SHA). Although it mentions primary insider transactions, the core announcement is the capital increase resulting from option exercises, making SHA the most specific fit over DIRS or CAP, which are broader or less direct fits for this specific event.
2021-12-03 English
Major shareholder disclosure in Photocure ASA
Major Shareholding Notification Classification · 99% confidence The document is titled 'Standard form for notification of major holdings' and contains structured fields detailing the acquisition/disposal of voting rights, the identity of the shareholder (Skandinaviska Enskilda Banken), the date the threshold was crossed (2021-12-01), and the resulting percentage of voting rights (5.20%). This format is characteristic of regulatory filings related to changes in significant share ownership, specifically mandated by EU directives (referenced by Article 9 and 10) for notifying major holdings to the issuer and competent authority. This directly corresponds to the definition of Major Shareholding Notification (MRQ).
2021-12-02 English
Major shareholder disclosure in Photocure ASA
Major Shareholding Notification Classification · 95% confidence The document text is extremely short (137 characters) and explicitly states 'Please see attachment on www.newsweb.no'. This indicates the document is an announcement pointing to the actual filing, not the filing itself. The content mentions 'Major shareholder disclosure'. This strongly aligns with the definition of a Major Shareholding Notification (MRQ), which reports changes in significant share ownership levels. Since this is a brief announcement pointing elsewhere, the Report Publication Announcement (RPA) or Regulatory Filing (RNS) might be considered, but given the specific subject matter ('Major shareholder disclosure'), MRQ is the most accurate content classification, and the short length suggests it's the announcement of that disclosure.
2021-12-02 English
Photocure ASA: Results for the third quarter of 2021
Earnings Release Classification · 99% confidence The document explicitly states 'Highlights for third quarter 2021' and presents detailed financial tables comparing Q3 2021 results against Q3 2020 and Year-to-Date figures. It includes an Income Statement breakdown, CEO commentary on performance, and operational reviews segmented by geography (U.S. and Europe). This structure, focusing on a specific, shorter reporting period (quarterly) with comprehensive financial details, strongly indicates an Interim/Quarterly Report. It is too detailed to be just an Earnings Release (ER) and is not the full annual filing (10-K). Therefore, the classification is Interim / Quarterly Report (IR). Q3 2021
2021-11-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.